Effect of low density lipoprotein on adenosine receptor-mediated coronary vasorelaxation in vitro

Journal of Pharmacology and Experimental Therapeutics

Volumn 282, Issue 2, 1997, Pages 851-857

  Abebe, Worku ^a   Mustafa, S Jamal ^a  

^a EAST CAROLINA UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 [4 (2 CARBOXYETHYL)PHENETHYLAMINO]ADENOSINE 5' (N ETHYLCARBOXAMIDE); 2 CHLOROADENOSINE; ADENOSINE 5' (N ETHYLCARBOXAMIDE); ADENOSINE RECEPTOR; COPPER SULFATE; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; NITRIC OXIDE; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ANIMAL TISSUE; ARTERY ENDOTHELIUM; ARTICLE; ATHEROSCLEROSIS; CONTROLLED STUDY; CORONARY ARTERY DILATATION; HYPERCHOLESTEROLEMIA; MALE; MUSCLE RELAXATION; NONHUMAN; OXIDATION; PRIORITY JOURNAL; SWINE;

2-CHLOROADENOSINE; ADENOSINE; ADENOSINE-5'-(N-ETHYLCARBOXAMIDE); ANIMALS; CORONARY VESSELS; LIPOPROTEINS, LDL; MALE; NITRITES; OXIDATION-REDUCTION; PHENETHYLAMINES; RECEPTORS, PURINERGIC P1; SWINE; VASODILATION;

EID: 0030843595     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. ABEBE, W., MAKUJINA, S. AND MUSTAFA, S. J.: Adenosine receptor-mediated relaxation of porcine coronary artery in presence and absence of endothelium. Am. J. Physiol. 266: H2018-H1025, 1994.
2. ABEBE, W., HUSSAIN, T., OLANREWAJU, H. AND MUSTAFA, S. J.: Role of nitric oxide in adenosine receptor-mediated relaxation of porcine coronary artery. Am. J. Physiol. 269: H1672-H1678, 1995.
3. BERNE, R. M.: The role of adenosine in the regulation of coronary blood flow. Circ. Res. 47: 807-813, 1980.
4. CASTILLI, W. P. AND ANDERSON, K.: A population at risk: Prevalence of high cholesterol levels in hypertensive patients in the Framingham study. Am. J. Med. 80:(Suppl. 2A), 23-32, 1986.
5. COX, D. A. AND COHEN, M. L.: Effects of oxidized low density lipoprotein on vascular contraction and relaxation: clinical and pharmacological implications in atherosclerosis. Pharmacol. Rev. 48: 3-19, 1996a.
6. COX, D. A. AND COHEN, M. L.: Selective enhancement of 5-hydroxytryptamine-induced contraction of porcine coronary artery by oxidized low-density lipoprotein. J. Pharmacol. Exp. Ther. 276: 1095-1103, 1996b.
7. DESROSIERS, C. AND NEES, S.: Functional evidence for the presence of adenosine receptors in cultured coronary endothelial cells. Naunyn-Schmiedeberg Arch. Pharmacol. 336: 94-98, 1987.
8. DREUGNOT, C., PRIVAT, S., GUILLONNEAU, C., REGNIER, G., BOUZOM, F., VILAINE, J. AND LENAERS, A.: S12340: A potent inhibitor of the oxidative modification of low density lipoprotein in vitro and ex vivo in WHHL rabbits. J. Pharmacol. Exp. Ther. 269: 515-520, 1994.
9. EISENBERG, S., STEIN, Y. AND STEIN, O.: Phospholipases in arterial tissue: III Phosphatide acyl-hydrolase, lysophosphatide acyl-hydrolase and sphingomyelin choline phosphohydrolase in rat and rabbit aorta in different age groups. Biochem. Biophys. Acta 176: 557-569, 1969.
10. FLAVAHAN, N. A.: Atherosclerosis or lipoprotein-induced endothelial dysfunction: potential mechanisms underlying reduction in EDRF/nitric oxide activity. Circulation 85: 1927-1938, 1992.
11. GALLE, J., BASSENGE, E., AND BUSSET, R.: Oxidized low density lipoproteins potentiate vasoconstrictions to various agonists by direct interaction with vascular smooth muscle. Circ. Res. 66: 1282-1293, 1990.
12. GALLE, J., BENGEN, J., SCHOLLMEYER, P., AND WANNER, C.: Impairment of endothelium-dependent dilation in rabbit renal arteries by oxidized lipoprotein (a). Role of oxygen-derived radicals. Circulation 92: 1582-1589, 1995.
13. GUYTON, J. R., LENZ, M. L., MATHEWS, B., HUGHES, H., KARSAN, D., SELINGER, E. AND SMITH, C.V.: Toxicity of oxidized low density lipoproteins for vascular smooth muscle cells and partial protection by antioxidants. Atherosclerosis 118: 237-249, 1995.
14. HENRIKSEN, T., MAHONEY, E. M. AND STEINBERG, D.: Enhanced macrophage degradation of low density lipoprotein previously incubated with cultured endothelial cells: Recognition by receptor for acetylated low density lipoproteins. Proc. Natl. Acad. Sci. U.S.A. 78: 6499-6503, 1981.
15. HESSLER, J. R., MORE, D. W., LEWIS, L. J. AND CHISOLM, G. M.: Lipoprotein oxidation and lipoprotein-induced cytotoxicity. Atherosclerosis 3:215-222, 1983.
16. HIRATA, K., AKITA, H. AND YOKOYAMA, M.: Oxidized low density lipoprotein inhibits bradykinin-induced phosphoinositide hydrolysis in cultured bovine aortic endothelial cells. FEBS Lett. 287: 181-184, 1991.
17. KUGIYAMA, K., KERNS, S. A., MORRISETT, J. D., ROBERTS, R. AND HENRY, P. D.: Impairment of endothelium-dependent arterial relaxation by lysolecithin in modified low-density lipoproteins. Nature 344: 160-162, 1990.
18. LIAO, J. K., SHIN, W. S., LEE, W. Y. AND CLARK, S. L.: Oxidized low density lipoprotein decreases the expression of endothelial nitric oxide synthase. J. Biol. Chem. 270: 319-324, 1995.
19. LIU, S. Y., LU, X., CHOY, S., DEMBINSKI, T. C., HATCH, G. M., MYMIN, D., SHEN, X., ANGEL, A., CHOY, P. C. AND MAN, R. Y. K.: Alteration of lysophosphatidylchline content in low density lipoprotein after oxidative modification: relationship to endothelium-dependent relaxation. Cardiovasc. Res. 28: 1476-1481, 1994.
20. LOPEZ, J. A., ARMSTRONG, M. L., PIEGOR, S. D. J. AND HEISTAD, D. D.: Effect of early and advanced atherosclerosis on vascular responses to serotonin, thromboxane A2, and ADP. Circulation adenosine 79: 698-705, 1989.
21. MAKUJINA, S., SABOUNI, M. H., BHATIA, S., DOUGLAS, F. L. AND MUSTAFA, S. J.: Effect of GS-15943A on the relaxations produced by adenosine analogs in human blood vessels. Eur. J. Pharmacol. 187: 525-530, 1990.
22. MANGIN, E. L., KUGIYAMA, K., NGUY, J. H., KERNS, S. A. AND HENRY, P. D.: Effect of lysolipids and oxidatively modified low density lipoprotein on endothelium-dependent relaxation of rabbit aorta. Circ. Res. 72: 161-166, 1993.
23. MATUSUDA, Y., HIRATA, K., INOUE, N., SUEMATSU, M., KAWASHIMA, S., AKITA, H. AND YOKOMYMA, M.: High density lipoprotein reverses inhibitory effect of oxidized low density lipoprotein on endothelium-dependent arterial relaxation. Circ. Res. 72: 1103-1109, 1983.
24. NIU, X. L., LIU, L. -Y., HU, M. -L., CHEN, X.: Some similarities in vascular effects of oleic aci and oxidized low-density lipoproteins on rabbit aorta. J. Mol. Cell. Cardiol. 27: 531-539, 1995.
25. OLSSON, R. A. AND PEARSON, J. D.: Cardiovascular purinoceptors. Physiol. Rev. 70: 761-845, 1990.
26. PARTHASARATHY, S., BARNETT, J. AND FONG, L. G.: High-density lipoprotein inhibits the oxidative modification of low-density lipoprotein. Biochim. Biophys. Acta 1044: 275-283, 1990.
27. PORTMAN, O. W. AND ALEXANDER, M.: Lysophosphatidylcholine concentrations and metabolism in aortic intima plus inner media: Effect of nutritionally induced atherosclerosis. J. Lipid Res. 10: 158-165, 1969.
28. SCHIELE, J. O. AND SCHWABE, U.: Characterization of the adenosine receptor in microvascular coronary endothelial cells. Eur. J. Pharmacol. 269: 51-58, 1994.
29. SCHUH, J., NOVOGRODEKY, A. AND HOSCHEMEYER, R. H.: Inhibition of lymphocyte mitogenesis by oxidized low density lipoprotein. Biochem. Biophys. Res. Commun. 84: 763-766, 1978.
30. SELLKE, F. W., ARMSTRONG, M. L. AND HARRISON, D. G.: Endothelium-dependent vascular relaxation is abnormal in the coronary microcirculation of atherosclerotic primates. Circulation 81: 1586-1593, 1990.
31. SIMON, B. C., CUNNINGHAM, L. D. AND COHEN, R. A.: Oxidized low density lipoproteins cause contraction and inhibit endothelium-dependent relaxation in the pig coronary artery. J. Clin. Invest. 86:; 75-79, 1990.
32. STEINBERG, D., PARTHASARATHY, S., CAREW, T. E., KHOO, J. C. AND WITZTUM, J. L.: Beyond cholesterol: modifications of low density lipoprotein that increase its atherogenicity. N. Engl. J. Med. 320: 915-924, 1989.
33. STEINBERG, D.: The rediscovery of high density lipoprotein: A negative risk factor in atherosclerosis. Eur. J. Clin. Invest. 8: 107-109, 1978.
34. STEINBRECHER, U. P., PARTHASARATHY, S., LEAKE, D. S., WITZTUM, J. L. AND STEINBERG, D.: Modification of low density lipoprotein by endothelial cells involves lipid peroxidation and degradation of low density lipoprotein phospholipids. Proc. Natl. Acad. Sci. U.S.A. 81: 3883-3887, 1984.
35. TANNER, F. C., NOLL, G., BOULANGER, C. M. AND LUSCHER, T. F.: Oxidized low density lipoproteins inhibit relaxations of porcine coronary arteries. Role of scavenger receptor and endothelium-derived nitric oxide. Circulation 88: 2012-2020, 1991.
36. TODA, N., MIYAZAKI, M., AND HAZAMA, F.: Functional and histological changes in mesenteric arteries and aortas from monkeys fed a high cholesterol diet. Jap. J. Pharmacol. 48: 441-451, 1988.
37. TOMITA, T., EZAKI, M., MIWA, M., NAKAMURA, K., AND INOUE, Y.: Rapid and reversible inhibition of low density lipoprotein of the endothelium-dependent relaxation to hemostatic substances in porcine coronary arteries. Circ. Res. 66: 18-927, 1990.
38. YLA-HERTTUALA, S., PALINSKI, W., ROSENFELD, M. E., PARTHASARATHY, S., CAREW, T. E., BUTLER, S., WITZTUM, J. L. AND STEINBERG, D.: Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man. J. Clin. Invest. 84: 1086-1095, 1989.
39. YOKOYAMA, M., HIRATA, K., MIYAKE, R., AKITA, H., ISHIKAWA, Y. AND FUKUZAKI, H.: Lysophosphatidylcholine: Essential role in the inhibition of endothelium-dependent vasorelaxation by oxidized low density lipoprotein. Biochem. Biophys. Res. Commun. 168: 301-308, 1990.